Immunology and Immunotherapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of immunology and oncoImmunology. Papers aim to uncover the modulations of the immune system, active and passive immunotherapies, the diagnostic test based on specific markers and the use of new technologies to identify novel predictive factors to respond to immunotherapy. Topics include, but are not limited to in vivo/in vitro immune responses research; targeted therapies (including antibody research and vaccine research); virotherapy and oncolytic vaccines; use of nanoparticles and microvesicles for developing immunotherapeutics; etc.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer III (Deadline: 30 June 2022)
- Inhibitors of Key Targets of SARS-CoV-2 and Other Coronaviruses (Deadline: 30 June 2022)
- Mucocutaneous Manifestations of HIV after 40 Years from the First Case (Deadline: 30 June 2022)
- Neutrophils, Fast and Strong (Deadline: 30 June 2022)
- New Advance in Viral Immunogens and Vaccines (Deadline: 30 June 2022)
- Molecular Mechanisms in Anaphylaxis (Deadline: 30 June 2022)
- Bacterial and Viral Infection and Sepsis: From Pathogenesis to Therapeutic Strategies (Deadline: 30 June 2022)
- The Natural Products, the Immune Diseases and the Cancers (Deadline: 30 June 2022)
- Autoimmune Blistering Diseases (Deadline: 30 June 2022)
- T-cell Immunotherapy for Solid Tumors and Hematological Diseases (Deadline: 30 June 2022)
- The Role of Alarmins in Human Pathologies: Impact on Diagnostic and Therapeutic Approaches (Deadline: 30 June 2022)
- Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 30 June 2022)
- Poxviruses: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 June 2022)
- GABA, GABA-Receptors, and GAD in Immune System Function and Their Modulation for Therapeutic Outcomes (Deadline: 25 July 2022)
- State-of-the-Art Immunology and Immunotherapy in USA (Deadline: 31 July 2022)
- Molecular Research in Infectious Diseases (Deadline: 31 July 2022)
- Skin Cancer: From Pathophysiology to Novel Therapeutic Approaches 3.0 (Deadline: 31 July 2022)
- Vaccines and Antibodies for Therapy and Prophylaxis (Deadline: 31 July 2022)
- Pathogenesis and Treatment of Autoimmune and Inflammatory Diseases (Deadline: 31 July 2022)
- Neuroinflammation in Autoimmune Diseases (Deadline: 31 July 2022)
- Immunosuppressive Signaling Regulation in Cancer Development (Deadline: 31 July 2022)
- State-of-the-Art Immunology and Immunotherapy in Europe (Deadline: 31 July 2022)
- Novel Targets for Fibrosis Development: Macrophages as a Source of Ligands and Myofibroblast Transition (Deadline: 31 July 2022)
- Viral Vectors for Immunotherapy: Vaccines and Cancer Immunotherapy (Deadline: 31 July 2022)
- Epigenetic Regulation and Antitumor Immune Responses (Deadline: 31 July 2022)
- Angiogenesis and Inflammation in Biological Barriers 2.0 (Deadline: 15 August 2022)
- Development of the Microglia-Based Immunotherapy Strategy for Age-Related Neurodegenerative Disease (Deadline: 31 August 2022)
- Novel Biomarkers and Mechanisms Underlying HBV and HDV Infection (Deadline: 31 August 2022)
- Immunology in COVID-19 Disease: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 August 2022)
- Relationship between Serum Metabolites and Oxidative Stress, Inflammation, and Gut Microbiota (Deadline: 31 August 2022)
- Advanced Research in Early Pregnancy Loss (Deadline: 31 August 2022)
- Emerging Issues in COVID and T Cells (Deadline: 31 August 2022)
- New Advancements in Chronic Inflammatory Skin Disease (Deadline: 31 August 2022)
- Molecular Targets for Biological Therapies of Severe Asthma (Deadline: 31 August 2022)
- Inflammasome as a Promising Therapeutic Target (Deadline: 31 August 2022)
- Immune Dysfunction in Brain Disorders (Deadline: 31 August 2022)
- State-of-the-Art Immunology and Immunotherapy in Italy (Deadline: 31 August 2022)
- State-of-the-Art Immunology and Immunotherapy in Poland (Deadline: 31 August 2022)
- The Impact of Oral Microbiota-Immunity Axis in Oral and Systemic Diseases (Deadline: 31 August 2022)
- Therapeutic Approaches to Endometriosis-Related Infertility (Deadline: 31 August 2022)
- Innate Immune Memory in Health and Disease (Deadline: 30 September 2022)
- Rett Syndrome: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 September 2022)
- Mechanism and Modulation in Sepsis 2.0 (Deadline: 30 September 2022)
- Immune-Mediated Skin Diseases: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 30 September 2022)
- The Role of Cytokines and Chemokines in the Pathogenesis of Systemic Sclerosis (Deadline: 30 September 2022)
- The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment (Deadline: 30 September 2022)
- Breaking through the Barricades: Immune Checkpoint Molecules and Immunotherapy in Cancer (Deadline: 30 September 2022)
- Immune Checkpoints and Autoimmunity (Deadline: 30 September 2022)
- Immunotherapy for Combatting Genitourinary Tract Cancers (Deadline: 30 September 2022)
- Local and Targeted Therapies in Glioblastoma Multiforme (Deadline: 30 September 2022)
- Past, Present and Future of COVID-19 (Deadline: 30 September 2022)
- Involvement of Pro-inflammatory Mediators in Chronic Inflammatory Diseases and Related Psychiatric Disorders (Deadline: 30 September 2022)
- Immunodeficiency Diseases: At the Crossroad between Infections, Immune Dysregulation and Cancers (Deadline: 30 September 2022)
- Roles of Endoplasmic Reticulum Stress in Immune Responses (Deadline: 31 October 2022)
- Macrophages in Health and Non-infectious Disease 3.0 (Deadline: 31 October 2022)
- Role of Peptides and Peptidases in Immune Responses (Deadline: 31 October 2022)
- Pancreatic Ductal Adenocarcinoma: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 October 2022)
- Advanced Research in the Central Nervous System: Crosstalk between Systemic Inflammation and Neurodegenerative Disorders (Deadline: 31 October 2022)
- Immune Response to Viruses and Bacteria (Deadline: 31 October 2022)
- Immunoglobulins in Inflammation 2.0 (Deadline: 31 October 2022)
- Cellular and Immunotherapy for Acute Lymphoblastic Leukemia (Deadline: 31 October 2022)
- The Role of Nanoparticles in Tumor Therapy (Deadline: 31 October 2022)
- Immunity to SARS-CoV-2: Humoral and Cellular Immune Response (Deadline: 31 October 2022)
- Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches 2.0 (Deadline: 31 October 2022)
- The Herpesvirus–Host Interactions (Deadline: 31 October 2022)
- Vitamin D in Health and Disease 2.0 (Deadline: 31 October 2022)
- The Role of Macrophage and Neutrophils in Angiogenesis (Deadline: 31 October 2022)
- 10th Anniversary of Biomedicines—Immunometabolism: Molecular Cross-Roads between Endogenous and Viral Pathology (Deadline: 15 November 2022)
- 10th Anniversary of Biomedicines: The Development of Cancer Immunotherapy (Deadline: 15 November 2022)
- Cancer: Immunology and Immunotherapy (Deadline: 15 November 2022)
- 10th Anniversary of Biomedicines—Intestinal Homeostasis and the Crosstalk within the Gut-Liver Axis (Deadline: 15 November 2022)
- 10th Anniversary of Biomedicines—Langerhans Cells in Health and Disease (Deadline: 15 November 2022)
- 10th Anniversary of Biomedicines-Immune-Aging (Deadline: 15 November 2022)
- 10th Anniversary of Biomedicines-Immunopathogenesis of Autoimmune Diseases (Deadline: 15 November 2022)
- Innate Immune Responses in Virus Infection (Deadline: 30 November 2022)
- Chronic Inflammatory Skin Diseases: From Bench to Bedside (Deadline: 30 November 2022)
- Clinical Immunology in Italy, with Special Emphasis to Primary and Acquired Immunodeficiencies: A Commemorative Issue in Honor of Prof. Fernando Aiuti (Deadline: 30 November 2022)
- Autoimmunity and Immune-Dysregulation in Hematological Diseases (Deadline: 30 November 2022)
- The Interplay between Immunity and Microbiota in Human Health and Diseases (Deadline: 30 November 2022)
- Neutrophils, Fast and Strong 2.0 (Deadline: 30 November 2022)
- Neutrophil Extracellular Traps (NETs) in Immunity (Deadline: 31 December 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
